Pubblicazioni

Autori:

Vergari, A; Cortegiani, A; Rispoli, M; Coluzzi, F; Deni, F; Leykin, Y; Luca Lorini, F; Martorano, P P; Paolicchi, A; Polati, E; Scardino, M; Corcione, A; Giarratano, A; Rossi, M

Titolo:

Sufentanil Sublingual Tablet System: from rationale of use to clinical practice

Anno:

2020

Tipologia prodotto:

Articolo in Rivista

Tipologia ANVUR:

Articolo su rivista

Lingua:

Inglese

Referee:

No

Nome rivista:

European Review of Medical and Pharmacological Science

ISSN Rivista:

1128-3602

N° Volume:

24

Numero o Fascicolo:

22

Intervallo pagine:

11891-11899

Parole chiave:

SSTS; Neuropathic pain; Surgery; Clinical practice

Breve descrizione dei contenuti:

The control of post-operative pain in Italy and other western countries is still suboptimal. In recent years, the Sufentanil Sublingual Tablet System (SSTS; Zalviso; Acel-Rx Pharmaceuticals, Redwood City, CA, USA), which is designed for patient-controlled analgesia (PCA), has entered clinical practice. SSTS enables patients to manage moderate-to-severe acute pain during the first 72 postoperative hours directly in the hospital setting. However, the role of SSTS within the current framework of options for the management of post-operative pain needs to be better established. This paper presents the position on the use of SSTS of a multidisciplinary group of Italian Experts and provides protocols for the use of this device.

Id prodotto:

119558

Handle IRIS:

11562/1037187

ultima modifica:

13 novembre 2022

Citazione bibliografica:

Vergari, A; Cortegiani, A; Rispoli, M; Coluzzi, F; Deni, F; Leykin, Y; Luca Lorini, F; Martorano, P P; Paolicchi, A; Polati, E; Scardino, M; Corcione, A; Giarratano, A; Rossi, M, Sufentanil Sublingual Tablet System: from rationale of use to clinical practice «European Review of Medical and Pharmacological Science» , vol. 24 , n. 22 , 2020 , pp. 11891-11899

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo